Senior insider sale
Chief Commercial Officer at TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$198.3K
8.25K shares
What this filing means
HEERMA PETER plans to sell 8.25K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $198.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/31/2025ACC: 0001959173-25-006629
Officer· Chief Commercial Officer
Since Oct 2019
8.25K
Shares to sell
$198.3K
Approx. market value
5.59K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
Restricted Stock Vesting
Compensation
1/31/2022
1.13KRestricted Stock Vesting
Compensation
2/4/2021
1.57KRestricted Stock Vesting
Compensation
2/1/2021
1.58KRestricted Stock Vesting
Compensation
10/1/2020
1.31KTotal acquired5.59K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/31/2022 | Restricted Stock Vesting Compensation | 1.13K | — |
2/4/2021 | Restricted Stock Vesting Compensation | 1.57K | — |
2/1/2021 | Restricted Stock Vesting Compensation | 1.58K | — |
10/1/2020 | Restricted Stock Vesting Compensation | 1.31K | — |
| Total | 5.59K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.66K
Market value
$2.7K
10/28/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
5.59K
Market value
$195.7K
10/31/2025
Total
Units
8.25K
Value
$198.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/28/2025 | 2.66K | $2.7K | — | Completed |
| Planned — Approximate Date | ||||
10/31/2025 | 5.59K | $195.7K | NASDAQ | Planned |
| Total | 8.25K | $198.3K | ||